From Texas Health and Human Services Commission <[email protected]>
Subject Draft Specialty Drug List Available for Comment, Responses Due March 17
Date March 2, 2023 3:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


Draft Specialty Drug List Available for Comment, Responses Due March 17

The draft specialty drug list [ [link removed] ] is now available for public comment. HHSC will accept comments until Friday, March 17.

*Upcoming clinical prior authorization changes:*


* Olumiant - Scheduled for March 27 [ [link removed] ]
* Antimigraine Agents (Triptans) - April 4 [ [link removed] ]
* Calcitonin Gene-Related Peptide Receptor Antagonists - April 4 [ [link removed] ]

 









________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis